Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D for Prevention of Paclitaxel-Induced Neuropathy
NCT06596122Phase 2Not yet recruiting
- Start
- Oct 2024
- Primary completion
- Nov 2026
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of vitamin d in peripheral neuropathy. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
vitamin d
03
Conditions
peripheral neuropathy
Beyond the preview
Go deeper on NCT06596122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06596122.